U.S. FDA considering new requirements for off-label use data
March 12, 2014 by MassDevice
By Stewart Eisenhart, Emergo Group
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
By Stewart Eisenhart, Emergo Group
Biomet is planning to put itself back on the public market after a 7-year run under private equity ownership, the orthopedics giant said today.
The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical device company’s nominees for director.
EarLens said it raised some $36 million in an equity round for the hearing aid technology it’s developing that uses infrared rather than sound waves.
February Summary
Class I recalls: 30
Class II recalls: 170
Recalling Manufacturer, Date Posted, Trade Name/Product, Reason for Recall
Medtronic says it plans to offer $2 billion worth of senior notes